About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Chicago | 109 Studies

Clinical Trials COPDChicago

COPD Clinical Trials in Chicago

Find 109 clinical trials for copd near Chicago, Illinois. Connect with research centers in your area.

All COPD trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 109 trials

CompletedLong-term Oxygen Treatment TrialChronic obstructive pulmonary disease (COPD) is a serious respiratory disease in which the airways in the lungs are partially blocked, resulting in symptoms of chest tightness…NCT00692198·Birmingham, Alabama and 38 others

PreviousPage 3 of 6Next

COPD Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseThis study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance…NCT05037929·Dothan, Alabama and 180 others

CompletedRETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeThe study hypothesis is that symptomatic current and former smokers with spirometric values within the normal range (post-bronchodilator FEV1/FVC≥0.70 and post-BD FVC ≥ 70%…NCT02867761·Birmingham, Alabama and 15 others

RecruitingAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaThis is a prospective, open-label, multi-center, single-arm study planned to enroll 200 subjects with heterogeneous emphysema and collateral ventilation (CV) in the target lobe.NCT06035120·Phoenix, Arizona and 37 others

CompletedPrevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)Alpha-1 antitrypsin deficiency (AATD) is considered a rare genetic cause of chronic obstructive pulmonary disease (COPD) and liver disease.NCT01419158·Los Angeles, California and 18 others

TerminatedEffects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)This is a phase 2, Multi-center, double-blind, randomized, placebo-controlled study to evaluate the effects of inhaled Iloprost in patients with pulmonary hypertension secondary…NCT01437878·Torrance, California and 10 others

CompletedComparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseDirect comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies.NCT01126437·Athens, Alabama and 1190 others

CompletedADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations.NCT00144911·Birmingham, Alabama and 96 others

CompletedRacial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-SharingIn partnership with a large Medicare Advantage (MA) insurer (Humana, Inc.) and as part of a Center for Medicare and Medicaid Innovation demonstration program of Value-Based…NCT05497999·Chicago, Illinois and 2 others

CompletedThe CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad…NCT03581227·Los Angeles, California and 7 others

CompletedNurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)This is a 16 week exercise training program for people with severe to very severe chronic obstructive pulmonary disease (COPD).NCT01058213·Chicago, Illinois

Active not recruitingEvaluation of the Safety and Efficacy of TLD in Patients with COPDThe purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.NCT03639051·Birmingham, Alabama and 32 others

TerminatedPromoting Activity After COPD Exacerbations, Aim 2This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and…NCT03793192·Chicago, Illinois

CompletedCOPD Assessment and Management Bundle Versus Usual CareChronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory (lung) disease that makes it harder to breathe over time.NCT01833026·Chicago, Illinois

WithdrawnAn Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPDThe objective of this study is to determine if inpatient COPD education would result in improved patient knowledge of COPD.NCT03323190·Chicago, Illinois

CompletedINtervention Study In overweiGHT Patients With COPDSymptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap.NCT02634268·Birmingham, Alabama and 38 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsThe purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with…NCT00206154·Birmingham, Alabama and 211 others

CompletedAddressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start StudyChronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression.NCT04043728·Chicago, Illinois

CompletedA Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDThe purpose of this study is to determine if SYMBICORT® delivered via a pressurized metered-dose inhaler, referred to as a pMDI, is effective in preventing COPD exacerbations.NCT00419744·Jasper, Alabama and 139 others

RecruitingDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Depemokimab is being developed as a treatment for individuals with moderate to severe COPD.NCT06961214·Sheffield, Alabama and 158 others

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia